Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 119 (1) , 145-149
- https://doi.org/10.1016/s0165-5728(01)00371-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosisJournal of Neuroimmunology, 2001
- Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosisAnnals of Neurology, 1999
- Increased release of interleukin-12p40 in MSNeurology, 1998
- Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.Journal of Clinical Investigation, 1998
- Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosisAnnals of Neurology, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- The role of IL-12 in the induction of organ-specific autoimmune diseasesImmunology Today, 1995
- Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.The Journal of Experimental Medicine, 1995
- Longitudinal MRI in multiple sclerosisNeurology, 1994
- Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosisAnnals of Neurology, 1992